What Is HAND?
HIV-Associated Neurocognitive Disorder — HAND — is an umbrella term for a spectrum of cognitive, behavioral, and motor impairments caused by HIV's effects on the central nervous system1. It ranges from subtle difficulties in thinking and memory that may only be detectable on formal neuropsychological testing, to significant impairment that affects daily functioning and independence.
HAND is not a new phenomenon. In the pre-treatment era, severe HIV dementia — called AIDS Dementia Complex — was a devastating and common complication of advanced HIV disease. Antiretroviral therapy dramatically reduced the incidence of severe dementia10. But it did not eliminate HAND. Milder forms of neurocognitive impairment persist in a substantial proportion of PLHIV even on effective treatment — and the reasons why are still being actively researched.
Older studies reported substantial cognitive impairment, but estimates vary with the population and definition. Current expert recommendations warn that test-based HAND criteria can overclassify impairment; a low score alone does not establish HIV-related brain injury.[11]2
Cognitive difficulties are not a measure of intelligence or a personal failing. Their cause needs assessment; symptoms alone cannot show that HIV has injured the brain.
Why HAND Happens — Even With an Undetectable Viral Load
One of the most important and most confusing aspects of HAND is that it can occur — and persist — even in people with undetectable blood viral loads on effective ART6. Understanding why requires understanding how HIV interacts with the brain differently than with the rest of the body.
The CNS Reservoir — Why the Brain Is Different
HIV can persist in cells within the central nervous system. That does not mean ongoing brain viral replication is the usual explanation for symptoms during suppressive ART. Symptomatic escape of HIV into cerebrospinal fluid is uncommon and requires specialist evaluation.[12]
Inflammation and injury before treatment may contribute to later cognitive difficulties. Researchers also study HIV persistence within brain immune cells, but these mechanisms do not establish the cause of any one person’s symptoms.3
This is why HAND is not fully explained by blood viral load, and why achieving undetectable status — while the most important intervention — does not guarantee cognitive preservation.
Additional factors contribute to HAND risk and severity in PLHIV. Age — the interaction between HIV-related neuroinflammation and normal brain aging — is increasingly recognized as a major factor, particularly for long-term survivors5. Cardiovascular risk factors, including hypertension, diabetes, and lipid abnormalities — all more common in PLHIV — independently affect brain health8. Depression, which is highly prevalent in PLHIV and itself impairs cognition, can both mimic and worsen HAND. Medication effects are one consideration in a wider assessment. A history of older ART use does not establish the cause of current memory or concentration problems; long-term survivors deserve an individual evaluation. See our guide to care and cognitive assessment.
The Three Historical HAND Categories
The 2007 research framework uses the categories below. They are not an inevitable sequence toward dementia, and clinicians must interpret test results alongside daily functioning and other possible causes.
What HAND Feels Like — Symptoms to Know
The symptoms of milder HAND — the forms most common in people on effective ART — are often subtle enough that they are dismissed as stress, aging, depression, or simply "brain fog." This is one of the primary reasons HAND goes undiagnosed. Knowing what to watch for — and how to describe it to your provider — is essential.
Common Symptoms of HAND in the ART Era
- Processing speed slowing: Thinking feels slower than it used to — taking longer to follow conversations, slower to respond, difficulty keeping up with fast-moving discussions
- Memory difficulties: Forgetting recent conversations, appointments, or where things were put — short-term memory more affected than long-term
- Word-finding difficulties: Losing words mid-sentence, knowing what you want to say but being unable to retrieve the word — sometimes called "tip of the tongue" phenomenon happening more frequently
- Executive function changes: Difficulty planning, organizing, multitasking, or managing complex tasks like finances, scheduling, or problem-solving
- Attention and concentration: Difficulty sustaining focus, being easily distracted, losing track in conversations or while reading
- Motor slowing: Subtle changes in coordination, handwriting, or fine motor tasks — sometimes noticed by others before the person themselves
- Behavioral and mood changes: Apathy, irritability, depression, or personality changes that seem out of character — these can be neurological rather than purely psychological
HAND vs. Depression vs. Normal Aging — Why It Matters
Depression, sleep disorders, medications, aging, and neurological illness can produce overlapping symptoms. Start with a clinical assessment; formal neuropsychological testing may help when the cause or functional impact remains uncertain. Sudden confusion, new weakness, or speech difficulty needs urgent assessment, not a routine HAND appointment.
Getting a HAND Diagnosis
Diagnosis combines medical history, changes in everyday functioning, examination, and appropriately interpreted cognitive testing. Brief screening tools can identify a reason for further assessment but do not, by themselves, prove or exclude HAND. Tests must fit language, education, and cultural background.
The Diagnostic Process
- Raise it with your HIV provider: Start the conversation. Describe specific examples of what you're experiencing — not just "my memory is bad" but "I lost a word I know in the middle of a meeting" or "I've been paying the same bill twice because I can't track it." Specifics matter.
- Look for other causes: Your clinician can review sleep, mood, medications, substance use, and relevant laboratory tests such as thyroid or B12 testing. Glucose-based testing may be needed because HbA1c can underestimate blood glucose in people taking ART. Tests should fit the history, rather than a mandatory panel for everyone.
- Referral to neuropsychology: Formal neuropsychological testing is the standard for HAND diagnosis. Ask for a referral to a neuropsychologist — ideally one with HIV experience. Testing typically takes 2–4 hours and provides a detailed profile of cognitive strengths and weaknesses.
- Brain MRI: Neuroimaging can identify structural brain changes associated with HIV — white matter abnormalities, brain atrophy, or other findings. An MRI is often part of the workup for new cognitive symptoms in PLHIV.
- CSF analysis: In some cases — particularly when CNS viral replication is suspected — a lumbar puncture (spinal tap) to analyze cerebrospinal fluid may be warranted. CSF viral load can be detectable even when blood viral load is undetectable.
What Helps — Treatment and Management
There is no medication specifically approved for HAND. Management focuses on optimizing ART, addressing contributing factors, and cognitive rehabilitation. The good news is that several of these interventions have meaningful evidence behind them.
Evidence-Based Approaches to HAND Management
- ART review: A higher CNS penetration-effectiveness score is not a reason on its own to switch treatment. For documented symptomatic CSF escape, specialists use resistance results and the full clinical picture. NIH does not support empiric intensification or switching for mild symptoms without documented escape.4
- Aggressive management of cardiovascular risk factors: Blood pressure control, cholesterol management, diabetes management, and smoking cessation all protect brain health and have evidence in slowing cognitive decline in the general population. In PLHIV, these risk factors compound HIV-related neuroinflammation — managing them is a direct intervention for brain health.
- Treatment of depression: Depression both mimics and worsens HAND. Effective depression treatment — medication, therapy, or both — can produce significant apparent improvement in cognitive symptoms, and distinguishes depression-driven cognitive impairment from HIV-driven impairment.
- Cognitive rehabilitation: Small trials suggest benefits on some tested skills. Effects on everyday functioning and durability need more study; ask whether tailored rehabilitation or compensatory strategies could help you.7
- Exercise: Physical activity supports general and cardiovascular health. Evidence for treating HIV-related cognitive impairment is still developing; choose an activity plan that fits your health and abilities.
- Sleep treatment: Poor sleep worsens cognitive performance significantly. PLHIV have high rates of sleep disorders including insomnia and sleep apnea — both of which impair the memory consolidation and neural repair that occurs during sleep. See our HIV & Sleep article for more.
Daily Strategies — Living and Working With HAND
Cognitive compensatory strategies — techniques that work around cognitive limitations rather than through them — can dramatically improve daily functioning for people living with HAND. These are not giving up. They are the same tools that elite performers and high-functioning people use when cognitive demands exceed cognitive capacity.
Practical Compensatory Strategies
- Externalize memory: Stop relying on internal memory for things that can be written down or tracked digitally. Calendar everything. Use reminders. Keep a notebook. The goal is to reduce the cognitive load on a system that is working harder than it should have to.
- Reduce multitasking: Multitasking is a myth for most people — and it is particularly costly for people with processing speed and attention difficulties. Single-task where possible. Close browser tabs. Put the phone down during conversations.
- Structure and routine: Predictable daily routines reduce the cognitive demand of decision-making and planning. The more that can be made automatic, the more cognitive resources are available for things that actually require them.
- Communicate with your workplace: If HAND is affecting your work, reasonable accommodations under the ADA may be available — extended deadlines, written rather than verbal instructions, reduced multitasking demands. See our HIV & Disability article for more on workplace rights.
- Simplify medication regimens: If you are on a complex medication schedule, cognitive impairment makes adherence harder — and repeated missed ART doses can jeopardize viral suppression. Discuss simplification to a once-daily single-tablet regimen with your provider if adherence is being affected.
- Tell people close to you: HAND symptoms can be misinterpreted by family, friends, and colleagues as inattentiveness, rudeness, or disengagement. Explaining what is happening — to the people you trust — can reduce interpersonal friction and build support.
Florida In Focus — Finding HAND Evaluation and Support
🌴 Florida In Focus: HAND
University of Miami — HIV Neurology: The University of Miami Miller School of Medicine can be a starting point for a neurology referral. Ask directly about current HIV and neuropsychology expertise, appointments, and coverage.
University of Florida Health — Neurology (Gainesville): UF Health's neurology program has experience with HIV-associated neurological conditions. For PLHIV in North and Central Florida, UF Health or Shands Hospital is a key referral destination for complex neurological presentations.
Ryan White neuropsychology referrals: Ask your Ryan White case manager whether neuropsychological testing is a covered service in your area. A referral through Ryan White may help with access; availability and coverage vary9.
VA Medical Centers (for veterans): Florida's VA system — including the Miami VA, Tampa VA, and Orlando VA — provides neuropsychological testing and HIV neurology services for eligible veterans living with HIV.
Memory and aging programs: Florida's academic medical centers have memory disorder programs — originally designed for Alzheimer's disease — that can also evaluate and support PLHIV with HAND. These programs often have neuropsychology, neurology, social work, and occupational therapy integrated.
Use the RiseUpToHIV Florida Locator to find HIV specialty care near you.
References & Sources
- Antinori et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 2007. Source. ↩
- Heaton et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy. Journal of NeuroVirology, 2011. Source. ↩
- Clifford and Ances. HIV-associated neurocognitive disorder. Lancet Infectious Diseases, 2013. Source. ↩
- BHIVA antiretroviral treatment guidelines, 2023 interim update. Cognitive impairment and limitations of CPE scoring. Source. ↩
- Valcour. HIV, aging, and cognition: emerging issues. 2013. Source. ↩
- Cysique and Brew. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. 2011. Source. ↩
- Evaluation of a Cognitive Rehabilitation Protocol in HIV Patients with Associated Neurocognitive Disorders: Efficacy and Stability Over Time. Source. ↩
- McIntosh et al. HIV, Vascular Risk Factors, and Cognition in the Combination Antiretroviral Therapy Era: A Systematic Review and Meta-Analysis. Source. ↩
- HRSA: Ryan White HIV/AIDS Program services. Source. ↩
- NIH/NINDS: Neurological Consequences of HIV and AIDS. Source. ↩
- International HIV-Cognition Working Group: Cognitive impairment in people living with HIV: consensus recommendations for a new approach (2023). Source. Checked September 20, 2026. ↩
- NIH: Virologic failure; neurological symptoms and CSF escape. Source. Checked September 20, 2026. ↩
For the full list of organizations and studies that inform RiseUpToHIV, visit our Sources page.